Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Instituto De Medicina Molecular João Lobo Antunes has 2 pending office actions in Biotechnology & Pharmaceuticals. The profile identifies 2 distinct examiners and 2 distinct art units. MCCORMICK, CATHERINE LYNN is the busiest examiner, with 1 pending matter. The record shows two separate examination paths for the institution’s biotechnology and pharmaceutical subject matter.
Counsel should manage the actions separately while coordinating terminology, disclosure positions, and any overlapping claim strategy. Each response should address the assigned examiner’s grounds and the relevant art-unit context rather than treating the actions as interchangeable. A coordinated review can prevent inconsistent statements, while matter-specific analysis remains necessary for amendments, cited art, and prosecution follow-up.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCCORMICK, CATHERINE LYNN | 1 | 52.3% | +39.8% |
| WESTON, ALYSSA G | 1 | 59.5% | +49.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17999087 | T Cells | WESTON, ALYSSA G | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18043276 | Genetic Construct | MCCORMICK, CATHERINE LYNN | 40d |
| 17999087 | T Cells | WESTON, ALYSSA G | — |
| Art Unit | Apps |
|---|---|
| 1638 | 1 |
| 1633 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18043276 | Genetic Construct | MCCORMICK, CATHERINE LYNN | 1638 | §103 | Final Rejection | 40d | Pending | Feb 27, 2023 |
| 17999087 | T Cells | WESTON, ALYSSA G | 1633 | §102§103§112 | Non-Final OA | — | Pending | Nov 17, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialInstituto De Medicina Molecular João Lobo Antunes has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Catherine Lynn Mccormick has the most, with 1 of Instituto De Medicina Molecular João Lobo Antunes's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
